Scinai Immunotherapeutics Announces $1.33 Million : comparem

JERUSALEM, Sept. 15, 2023 (GLOBE NEWSWIRE) -- via IBN – Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) a biopharmaceutical company focused on developing,...

Related Keywords

Jerusalem , Israel General , Israel , New York , United States , California , Los Angeles , European Investment Bank , Hc Wainwright Co , Exchange Commission , Exchange Commission On , Nasdaq , Corporate Communications , Company Annual Report On Form , Company American Depositary Shares Adss , Scinai Immunotherapeutics Ltd , American Depositary Shares , Securities Act , Private Litigation Reform Act , Annual Report , Nasdaq Scni , Iopharmaceutical , Cni , Registered Direct Offering ,